Entity

Time filter

Source Type

Bundoora, Australia

Baell J.B.,Walter and Eliza Hall Institute of Medical Research | Baell J.B.,Cancer Therapeutics CRC Pty Ltd
Future Medicinal Chemistry | Year: 2010

Academic drug discovery is being accompanied by a plethora of publications that report screening hits as good starting points for drug discovery or as useful tool compounds, whereas in many cases this is not so. These compounds may be protein-reactive but can also interfere in bioassays via a number of other means, and it can be very hard to prove early on that they represent false starts. This, for instance, makes it difficult for journals in their assessment of manuscripts submitted for publication. Wider awareness and recognition of these problematic compounds will help the academic drug-discovery community focus on and publish genuinely optimizable screening hits. This will be of general benefit. © 2010 Future Science Ltd.


Patent
Cancer Therapeutics CRC Pty Ltd | Date: 2012-07-06

A compound of the formula (I): where R


Patent
Cancer Therapeutics CRC Pty Ltd | Date: 2012-02-17

A compound of the formula (I): where R


Patent
CANCER THERAPEUTICS CRC PTY Ltd | Date: 2013-08-16

This invention relates to a compound of the formula (I): The invention also relates to processes for the preparation of the compound of the formula (I), pharmaceutical agents or compositions containing the compound or a method of using the compound for the treatment of proliferative diseases, such as cancer, as well as the treatment of diseases ameliorated by the control and/or inhibition of lymphangiogenesis.


Patent
Cancer Therapeutics CRC Pty Ltd | Date: 2012-07-06

A compound of the formula (I): where R

Discover hidden collaborations